Comparative Study on the Efficacy and Safety of Initial Combination Therapy of Low Dose Propiverine Hydrocholoride Compared to Alpha-antagonist Monotherapy in men with BPH with Overactive bladder : A Prospective Placebo Controlled Study.

Trial Profile

Comparative Study on the Efficacy and Safety of Initial Combination Therapy of Low Dose Propiverine Hydrocholoride Compared to Alpha-antagonist Monotherapy in men with BPH with Overactive bladder : A Prospective Placebo Controlled Study.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 02 Sep 2016

At a glance

  • Drugs Propiverine (Primary) ; Alfuzosin
  • Indications Benign prostatic hyperplasia; Overactive bladder
  • Focus Therapeutic Use
  • Acronyms SYNERGY
  • Most Recent Events

    • 13 Feb 2013 Planned End Date changed from 1 May 2013 to 29 Sep 2013 as reported by Korean Clinical Trials Register.
    • 09 May 2012 Planned end date 1 May 2013 added as reported by Korean Clinical Trials Register record.
    • 09 May 2012 Status changed from not yet recruiting to recruiting as reported by Korean Clinical Trials Register record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top